Literature DB >> 16395074

Evaluation of Pediatric Risk of Mortality (PRISM) scoring in African children with falciparum malaria.

Patrick Gérardin1, Christophe Rogier, Stéphane Leteurtre, Philippe Jouvencel, Amadou Sidy Ka, Patrick Imbert.   

Abstract

OBJECTIVE: Little is known about the use of generic severity scores in severe childhood infectious diseases. The purpose of this prospective study was to evaluate the performance of the Pediatric Risk of Mortality (PRISM) scoring system in predicting the outcome of falciparum malaria in African children. DESIGN, SETTING, PATIENTS: All children admitted to a 120-bed pediatric ward in a tertiary care hospital in Dakar, Senegal, with a primary diagnosis of acute malaria were assigned a PRISM score after 24 hrs or at time of death.
INTERVENTIONS: None.
RESULTS: PRISM discrimination, evaluated by areas under receiver operating characteristic curves (AUC), was good both for all acute malaria cases (n = 311; lethality, 9%; AUC, 0.89; 95% confidence interval [CI], 0.85-0.92) and for severe malaria cases (n = 233; lethality, 12%; AUC, 0.86; 95% CI, 0.81-0.90). However, the number of children who died was greater than the number of deaths predicted by PRISM (standardized mortality ratio, 2.16; 95% CI, 1.46-2.87).
CONCLUSION: This discrepancy observed in five classes of expected mortality (Hosmer-Lemeshow chi-square test, p < .001) may have been due to chance (sample size too small for a valid test), to a lower standard of care in Dakar than in the American hospitals where PRISM was designed, or to a failure of PRISM to classify risk in severe malaria.

Entities:  

Mesh:

Year:  2006        PMID: 16395074     DOI: 10.1097/01.pcc.0000192321.66637.e6

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  7 in total

1.  Initial predictive factors of outcome in severe non-accidental head trauma in children.

Authors:  Didier Scavarda; Charline Gabaudan; Fabrice Ughetto; Frederic Lamy; Vanessa Imada; Gabriel Lena; Olivier Paut
Journal:  Childs Nerv Syst       Date:  2010-05-12       Impact factor: 1.475

2.  Application of the pediatric risk of mortality (PRISM) score and determination of mortality risk factors in a tertiary pediatric intensive care unit.

Authors:  Graziela Araujo Costa; Arthur F Delgado; Alexandre Ferraro; Thelma Suely Okay
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

3.  Clinical and molecular characteristics of invasive community-acquired Staphylococcus aureus infections in Chinese children.

Authors:  Yanhong Qiao; Xue Ning; Qiang Chen; Ruizhen Zhao; Wenqi Song; Yuejie Zheng; Fang Dong; Shipeng Li; Juan Li; Lijuan Wang; Ting Zeng; Yanhong Dong; Kaihu Yao; Sangjie Yu; Yonghong Yang; Xuzhuang Shen
Journal:  BMC Infect Dis       Date:  2014-11-07       Impact factor: 3.090

4.  Severe imported malaria in children in France. A national retrospective study from 1996 to 2005.

Authors:  Pierre Mornand; Catherine Verret; Philippe Minodier; Albert Faye; Marc Thellier; Patrick Imbert
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

5.  Prognostic models for the clinical management of malaria and its complications: a systematic review.

Authors:  Tsi Njim; Bayee Swiri Tanyitiku
Journal:  BMJ Open       Date:  2019-11-26       Impact factor: 2.692

6.  Outcome of life-threatening malaria in African children requiring endotracheal intubation.

Authors:  Patrick Gérardin; Christophe Rogier; Amadou S Ka; Philippe Jouvencel; Bakary Diatta; Patrick Imbert
Journal:  Malar J       Date:  2007-04-30       Impact factor: 2.979

7.  Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) Score.

Authors:  Elizabeth C George; A Sarah Walker; Sarah Kiguli; Peter Olupot-Olupot; Robert O Opoka; Charles Engoru; Samuel O Akech; Richard Nyeko; George Mtove; Hugh Reyburn; James A Berkley; Ayub Mpoya; Michael Levin; Jane Crawley; Diana M Gibb; Kathryn Maitland; Abdel G Babiker
Journal:  BMC Med       Date:  2015-07-31       Impact factor: 11.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.